Definitive Healthcare Corp. (NASDAQ:DH) Shares Sold by Massachusetts Financial Services Co. MA

Massachusetts Financial Services Co. MA lessened its holdings in shares of Definitive Healthcare Corp. (NASDAQ:DH - Free Report) by 18.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,962,749 shares of the company's stock after selling 1,090,484 shares during the period. Massachusetts Financial Services Co. MA owned 4.30% of Definitive Healthcare worth $20,397,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Nisa Investment Advisors LLC increased its holdings in shares of Definitive Healthcare by 3,652.7% in the fourth quarter. Nisa Investment Advisors LLC now owns 6,980 shares of the company's stock valued at $29,000 after purchasing an additional 6,794 shares during the last quarter. Point72 DIFC Ltd grew its holdings in Definitive Healthcare by 759.9% in the 3rd quarter. Point72 DIFC Ltd now owns 9,296 shares of the company's stock valued at $42,000 after buying an additional 8,215 shares in the last quarter. Ieq Capital LLC acquired a new stake in shares of Definitive Healthcare in the 4th quarter worth $51,000. Intech Investment Management LLC purchased a new position in shares of Definitive Healthcare during the 3rd quarter worth $55,000. Finally, KLP Kapitalforvaltning AS acquired a new position in shares of Definitive Healthcare during the 4th quarter valued at about $54,000. Institutional investors and hedge funds own 98.67% of the company's stock.

Definitive Healthcare Trading Up 4.4 %

Shares of NASDAQ DH traded up $0.11 during trading on Friday, reaching $2.59. The stock had a trading volume of 1,182,186 shares, compared to its average volume of 856,655. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.49 and a current ratio of 2.49. The company has a market cap of $292.44 million, a P/E ratio of -0.84, a PEG ratio of 4.06 and a beta of 1.48. Definitive Healthcare Corp. has a fifty-two week low of $2.15 and a fifty-two week high of $7.66. The business's 50-day moving average price is $3.57 and its 200-day moving average price is $4.10.

Definitive Healthcare (NASDAQ:DH - Get Free Report) last released its earnings results on Thursday, February 27th. The company reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.07 by ($0.04). The firm had revenue of $62.29 million during the quarter, compared to analyst estimates of $60.60 million. Definitive Healthcare had a negative net margin of 142.38% and a positive return on equity of 1.76%. On average, equities research analysts predict that Definitive Healthcare Corp. will post 0.16 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on DH shares. Barclays cut their price objective on shares of Definitive Healthcare from $4.00 to $3.00 and set an "underweight" rating for the company in a research report on Monday, March 3rd. Stephens initiated coverage on shares of Definitive Healthcare in a research report on Friday, December 20th. They set an "equal weight" rating and a $5.00 price target on the stock. Needham & Company LLC reiterated a "hold" rating on shares of Definitive Healthcare in a report on Thursday, January 16th. Finally, The Goldman Sachs Group cut their target price on Definitive Healthcare from $4.50 to $3.00 and set a "neutral" rating for the company in a research note on Tuesday, March 4th. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have issued a buy rating to the company's stock. According to MarketBeat, Definitive Healthcare has an average rating of "Hold" and a consensus price target of $5.35.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.